{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T22:51:37Z","timestamp":1771455097169,"version":"3.50.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T00:00:00Z","timestamp":1676937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T00:00:00Z","timestamp":1676937600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Patients with Hodgkin lymphoma exhibit various clinical presentations. Needle biopsy of the lymph nodes is a minimally invasive procedure and a useful diagnostic method for malignant lymphomas. However, at times it is difficult to differentiate malignant lymphomas from reactive lymph node changes using a small amount of biopsy material.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A 77-year-old Japanese man was referred to the emergency department of our hospital owing to high fever and disturbance of consciousness. We diagnosed sepsis due to an acute biliary tract infection because he presented with Charcot\u2019s triad\u2014fever, jaundice, and right-sided abdominal pain. However, he did not respond well to antimicrobial therapy and his high fever persisted. Considering the swelling of the right cervical, mediastinal, and intraperitoneal lymph nodes and splenomegaly detected on computed tomography, a differential diagnosis of malignant lymphoma was needed. Hence, we performed a needle biopsy of the right cervical lymph node; however, the amount of sample obtained was insufficient in establishing a definitive diagnosis of malignant lymphoma. Furthermore, during hospitalization, the patient developed thrombocytopenia, anasarca, and renal insufficiency. These symptoms seemed to be the typical signs of the thrombocytopenia, anasarca, fever, reticulin fibrosis or renal insufficiency, and organomegaly syndrome. Next, an external incisional mass biopsy of the right cervical lymph node was performed, which helped identify Hodgkin and Reed\u2013Sternberg cells. Collectively, we established a definitive diagnosis of Hodgkin lymphoma with lymphoma-associated hemophagocytic syndrome.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This case highlights the importance of performing an external incisional mass biopsy of the lymph nodes for the early diagnosis and treatment, if malignant lymphoma is strongly suspected.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13256-023-03776-6","type":"journal-article","created":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T01:02:28Z","timestamp":1676941348000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Thrombocytopenia, anasarca, and renal insufficiency as severe and rare complications of Hodgkin lymphoma: a case report"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2811-4371","authenticated-orcid":false,"given":"Tatsuya","family":"Kikuchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinori","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kouichi","family":"Ichimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Okada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryoichi","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,2,21]]},"reference":[{"issue":"21","key":"3776_CR1","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1056\/NEJM199811193392104","volume":"339","author":"D Hasenclever","year":"1998","unstructured":"Hasenclever D, Diehl V. A prognostic score for advanced Hodgkin\u2019s disease. International Prognostic Factors Project on Advanced Hodgkin\u2019s Disease. N Engl J Med. 1998;339(21):1506\u201314.","journal-title":"N Engl J Med"},{"issue":"19","key":"3776_CR2","doi-asserted-by":"publisher","first-page":"3128","DOI":"10.1200\/JCO.2005.05.2746","volume":"24","author":"EM Noordijk","year":"2006","unstructured":"Noordijk EM, et\u00a0al. Combined-modality therapy for clinical stage I or II Hodgkin\u2019s lymphoma: long-term results of the European Organisation for Research and Treatment of Cancer H7 randomized controlled trials. J Clin Oncol. 2006;24(19):3128\u201335.","journal-title":"J Clin Oncol"},{"key":"3776_CR3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40560-017-0270-8","volume":"6","author":"O Nishida","year":"2018","unstructured":"Nishida O, et\u00a0al. The Japanese clinical practice guidelines for management of sepsis and septic shock 2016 (J-SSCG 2016). J Intensive Care. 2018;6:7.","journal-title":"J Intensive Care"},{"issue":"8","key":"3776_CR4","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, et\u00a0al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801\u201310.","journal-title":"JAMA"},{"issue":"5","key":"3776_CR5","first-page":"320","volume":"51","author":"K Takai","year":"2010","unstructured":"Takai K, et\u00a0al. Thrombocytopenia with mild bone marrow fibrosis accompanied by fever, pleural effusion, ascites and hepatosplenomegaly. Rinsho Ketsueki. 2010;51(5):320\u20135.","journal-title":"Rinsho Ketsueki"},{"issue":"1","key":"3776_CR6","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3960\/jslrt.53.57","volume":"53","author":"H Kawabata","year":"2013","unstructured":"Kawabata H, et\u00a0al. Castleman-Kojima disease (TAFRO syndrome): a novel systemic inflammatory disease characterized by a constellation of symptoms, namely, thrombocytopenia, ascites (anasarca), microcytic anemia, myelofibrosis, renal dysfunction, and organomegaly\u202f: a status report and summary of Fukushima (6 June, 2012) and Nagoya meetings (22 September, 2012). J Clin Exp Hematop. 2013;53(1):57\u201361.","journal-title":"J Clin Exp Hematop"},{"issue":"6","key":"3776_CR7","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1007\/s12185-016-1979-1","volume":"103","author":"Y Masaki","year":"2016","unstructured":"Masaki Y, et\u00a0al. Proposed diagnostic criteria, disease severity classification and treatment strategy for TAFRO syndrome, 2015 version. Int J Hematol. 2016;103(6):686\u201392.","journal-title":"Int J Hematol"},{"issue":"9","key":"3776_CR8","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1002\/ajh.25554","volume":"94","author":"S Fujimoto","year":"2019","unstructured":"Fujimoto S, et\u00a0al. Is TAFRO syndrome a subtype of idiopathic multicentric Castleman disease? Am J Hematol. 2019;94(9):975\u201383.","journal-title":"Am J Hematol"},{"issue":"20","key":"3776_CR9","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1182\/blood-2018-07-862334","volume":"132","author":"F van Rhee","year":"2018","unstructured":"van Rhee F, et\u00a0al. International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease. Blood. 2018;132(20):2115\u201324.","journal-title":"Blood"},{"issue":"1","key":"3776_CR10","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s12185-019-02780-1","volume":"111","author":"Y Masaki","year":"2020","unstructured":"Masaki Y, et\u00a0al. 2019 Updated diagnostic criteria and disease severity classification for TAFRO syndrome. Int J Hematol. 2020;111(1):155\u20138.","journal-title":"Int J Hematol"},{"key":"3776_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmoldx.2022.06.002","author":"J Song","year":"2022","unstructured":"Song J, et\u00a0al. Utility of Epstein\u2013Barr viral load in blood for diagnosis and predicting prognosis of lymphoma: a comparison with Epstein\u2013Barr virus-encoded RNA in situ hybridization. J Mol Diagn. 2022. https:\/\/doi.org\/10.1016\/j.jmoldx.2022.06.002.","journal-title":"J Mol Diagn"},{"issue":"1","key":"3776_CR12","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s00277-002-0572-2","volume":"82","author":"H Kojima","year":"2003","unstructured":"Kojima H, et\u00a0al. Hemophagocytic syndrome as the primary clinical symptom of Hodgkin\u2019s disease. Ann Hematol. 2003;82(1):53\u20136.","journal-title":"Ann Hematol"},{"key":"3776_CR13","first-page":"6672257","volume":"2021","author":"J Komisarof","year":"2021","unstructured":"Komisarof J, et\u00a0al. An atypical presentation of hemophagocytic lymphohistiocytosis (HLH) secondary to occult Hodgkin lymphoma. Case Rep Hematol. 2021;2021:6672257.","journal-title":"Case Rep Hematol"},{"issue":"1","key":"3776_CR14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13256-020-02588-2","volume":"15","author":"S Minomo","year":"2021","unstructured":"Minomo S, et\u00a0al. A severe case of thrombocytopenia, anasarca, fever, renal insufficiency or reticulin fibrosis, and organomegaly syndrome with myocardial and skeletal muscle calcification despite hypocalcemia: a case report. J Med Case Rep. 2021;15(1):3.","journal-title":"J Med Case Rep"},{"issue":"3","key":"3776_CR15","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1159\/000518079","volume":"14","author":"C Williams","year":"2021","unstructured":"Williams C, et\u00a0al. TAFRO syndrome and elusive diagnosis of idiopathic multicentric castleman disease treated with empiric anti-interleukin-6 therapy. Case Rep Oncol. 2021;14(3):1359\u201365.","journal-title":"Case Rep Oncol"},{"key":"3776_CR16","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.9160-21","author":"H Suzuki","year":"2022","unstructured":"Suzuki H, et\u00a0al. A case of TAFRO syndrome that responded to prednisolone-only treatment: evaluating changes in IL-6. Intern Med. 2022. https:\/\/doi.org\/10.2169\/internalmedicine.9160-21.","journal-title":"Intern Med"},{"issue":"12","key":"3776_CR17","doi-asserted-by":"publisher","first-page":"474","DOI":"10.14740\/jmc3784","volume":"12","author":"Y Otsuka","year":"2021","unstructured":"Otsuka Y, et\u00a0al. Successful treatment of thrombocytopenia, anasarca, fever, reticulin myelofibrosis\/renal insufficiency, and organomegaly syndrome using plasma exchange followed by rituximab in the intensive care unit. J Med Cases. 2021;12(12):474\u201380.","journal-title":"J Med Cases"},{"key":"3776_CR18","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.8366-21","author":"C Hidekawa","year":"2022","unstructured":"Hidekawa C, et\u00a0al. Anti-interferon-gamma antibody-seropositive disseminated nontuberculous mycobacterial infection mimicking POEMS and TAFRO syndromes: a case report. Intern Med. 2022. https:\/\/doi.org\/10.2169\/internalmedicine.8366-21.","journal-title":"Intern Med"},{"issue":"23","key":"3776_CR19","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.1200\/JCO.2016.66.4482","volume":"34","author":"MG Roemer","year":"2016","unstructured":"Roemer MG, et\u00a0al. PD-L1 and PD-L2 genetic alterations define classical Hodgkin lymphoma and predict outcome. J Clin Oncol. 2016;34(23):2690\u20137.","journal-title":"J Clin Oncol"},{"issue":"4","key":"3776_CR20","doi-asserted-by":"publisher","first-page":"182","DOI":"10.3960\/jslrt.21003","volume":"61","author":"A Sakakibara","year":"2021","unstructured":"Sakakibara A, et\u00a0al. Diagnostic utility of programmed cell death ligand 1 (clone SP142) immunohistochemistry for malignant lymphoma and lymphoproliferative disorders: a brief review. J Clin Exp Hematop. 2021;61(4):182\u201391.","journal-title":"J Clin Exp Hematop"},{"issue":"10","key":"3776_CR21","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1097\/PAS.0000000000001524","volume":"44","author":"A Volaric","year":"2020","unstructured":"Volaric A, Bacchi CE, Gru AA. PD-1 and PD-L1 immunohistochemistry as a diagnostic tool for classic Hodgkin lymphoma in small-volume biopsies. Am J Surg Pathol. 2020;44(10):1353\u201366.","journal-title":"Am J Surg Pathol"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-023-03776-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-023-03776-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-023-03776-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T01:03:26Z","timestamp":1676941406000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-023-03776-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,21]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3776"],"URL":"https:\/\/doi.org\/10.1186\/s13256-023-03776-6","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,21]]},"assertion":[{"value":"4 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for the publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"We do not have any potential conflicts of interest relevant to this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"61"}}